Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
Allele, antigen, asymptomatic, atoltivimab, bore, carefully, children, counsel, countermeasure, diagnose, disorder, duty, enjoined, ESMO, EUA, extortion, fatal, fiduciary, formula, fungal, gather, geographic, Inmazeb, InmazebTM, intervener, intervention, itepekimab, join, Journal, leaseback, lifted, load, maftivimab, MFN, nasal, notified, odronextamab, outpatient, Oxford, oxygen, pause, Paused, poor, proceed, purported, ransomware, recoup, RECOVERY, redeem, redeemed, repaid, repay, room, Secretary, Society, speculation, therewith, University, unrecognized, urgency, urgent, ventilation, Virtual, volunteer, Zaire
Removed:
concomitant, DMC, dose, favored, permission, restatement
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view